Chapter 20: Molecular Technologies
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The discussion then shifts to agricultural biotechnology, covering the engineering of crop plants for herbicide tolerance, insect resistance, and nutritional enhancement through techniques such as Agrobacterium-mediated transformation and particle bombardment. Transgenic livestock represent another application, with engineered animals serving purposes ranging from pharmaceutical production in milk to providing models for xenotransplantation research. The chapter explores functional genomics approaches, including gene knockout and knock-in strategies in model organisms, particularly mice, which enable researchers to determine gene function by observing phenotypic changes when genes are disrupted or replaced. Key technologies discussed include embryonic stem cell targeting, CRISPR-Cas9 systems, and zinc-finger nucleases as precision editing tools. Gene therapy receives substantial attention, with examination of both ex vivo approaches that modify cells outside the body and in vivo strategies that deliver corrective genes directly to patients, alongside discussions of clinical challenges including immune rejection, vector limitations, and potential off-target modifications. The chapter also covers molecular diagnostic and analytical methods, including microarray analysis for detecting mutations and expression patterns, quantitative PCR for measuring transcript abundance, and next-generation sequencing for comprehensive genomic assessment, all of which enable personalized medicine approaches. DNA fingerprinting and short tandem repeat analysis are presented as applications in forensic science and kinship determination. The chapter concludes by addressing the complex ethical, legal, and social dimensions of biotechnology, including concerns about genetic privacy, labeling of genetically modified foods, implications of germline editing, and intellectual property questions surrounding genetic patents, emphasizing the need for responsible governance and public engagement.